All In Biotech

Drug Trial Radar · NCT06195540

RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing

RIVACAST : RIVAroxaban Versus Low-molecular Weight Heparinin Patients With Lower Limb Trauma Requiring Brace or CASTing

Last checked: Nov 20, 2026Latest source record: Jun 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 1,424 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,424

Planned (sponsor's estimate)

Start

Jul 19, 2024

Primary completion

Nov 19, 2028

Study completion Nov 19, 2028

Sponsor

Lead sponsor
University Hospital, AngersGovernment (non-federal)
Sponsor type
Government (non-federal)
First posted
Jan 8, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Lower limb trauma requiring immobilization is a very frequent condition that is associated with an increased risk of developing venous thromboembolism (VTE). The TRiP(cast) score has been developed to provide individual VTE risk stratification and help in thromboprophylactic anticoagulation decision. The recent CASTING study had confirmed that patients with a TRiP(cast) score \<7 have a very low risk of VTE and could be safely manage without prophylactic treatment. Conversely, patients with a score ≥ 7 have a high-risk of VTE and require a prophylactic anticoagulant treatment. Low molecular weight heparins (LMWH) have been shown to be effective in this indication. However, in the CASTING study, the 3-month symptomatic VTE rate was 2.6% in this subgroup despite LMWH prophylactic treatment. This result suggests that LMWH are not sufficiently effective in this particular subgroup of high-risk patients. Direct oral anticoagulants, and in particular rivaroxaban, may be an effective and safe alternative to LMWH. In the PRONOMOS study, comparing LMWH with rivaroxaban in patients who had undergone non-major lower limb surgery, the relative risk of symptomatic VTE was 0.25 (95% CI = 0.09 - 0.75) in favor of rivaroxaban 10mg. No significant increase in bleeding was found. In addition, as LMWH treatment requires subcutaneous daily injections, the use of rivaroxaban may positively impact patients' quality of life as well as being effective in medico-economic terms. The aims of this study are to demonstrate that rivaroxaban is at least as effective, easier to use and more efficient than LMWH in patients with trauma to the lower limb requiring immobilisation and deemed to be at risk of venous thromboembolism (TRiP(cast) score ≥ 7). High-risk patients are randomized to receive either rivaroxaban or LMWH. They are followed up at 45 days and 90 days to assess the occurrence of thrombotic events or bleeding, as well as their satisfaction with the treatment received.

Conditions

  • Venous Thromboembolism
  • Deep Vein Thrombosis
  • Pulmonary Embolism
  • Lower Limb Trauma
  • Thromboprophylaxis
  • Immobilisation

Interventions

  • Rivaroxaban 10 MGDrug

    Administration of rivaroxaban 10 mg once daily to prevent venous thromboembolic events in patients with trauma to a lower limb. Consecutive patients with lower limb trauma and a TRiP(cast) score ≥ 7 are assessed for possible participation in the study. At the inclusion visit, if the patient meets the study's selection criteria, the investigator provides oral and written information (information letter written in a language the patient can understand) and answers any questions the patient may have. Depending on randomisation, the patient will receive either LMWH or rivaroxaban. The dose is rivaroxaban 10 mg orally once a day (no dosage adjustment). Treatment is started in the emergency department and continued at home for the duration of the immobilisation (i.e. until mobilisation with weight-bearing). The duration of treatment will be determined by the physician.

  • Low Heparin Molecular WeightDrug

    Administration of standard prophylactic anticoagulant treatment with LMWH for the duration of immobilisation (i.e. until full mobilisation with weight-bearing). Consecutive patients with lower limb trauma and a TRiP(cast) score ≥ 7 are assessed for possible participation in the study. At the inclusion visit, if the patient meets the study's selection criteria, the investigator provides oral and written information (information letter written in a language the patient can understand) and answers any questions the patient may have. Depending on randomisation, the patient will receive either LMWH or rivaroxaban. The dose of LMWH is free, given according to local practices and national recommendations. Treatment is started in the emergency department and continued at home for the duration of the immobilisation (i.e. until mobilisation with weight-bearing). The duration of treatment will be determined by the physician.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of symptomatic venous thromboembolic events (45 days non-inferiority)Time frame: 45 days

Locations

37 sites in 1 country. Site status is shown where the registry gives one.

  • Agen-Nerac Hospital, Emergency Department

    Agen, France · Active not recruiting

  • Angers University Hospital, Emergency department

    Angers, France · Recruiting

  • Argenteuil hospital, Emergency department

    Argenteuil, France · Recruiting

  • Arpajon Hospital, Emergency Department

    Arpajon, France · Withdrawn

  • Caen University hospital, Emergency department

    Caen, France · Withdrawn

  • Tours University Hospital, Emergency department

    Chambray-lès-Tours, France · Withdrawn

  • Cholet Hospital, Emergency department

    Cholet, France · Recruiting

  • Clermont-Ferrand University Hospital, Emergency department

    Clermont-Ferrand, France · Recruiting

  • Simone Veil Hospital, Emergency Department

    Eaubonne, France · Recruiting

  • Eure-Seine Hospital, Emergency Departement

    Évreux, France · Active not recruiting

  • Grenoble University Hospital, Emergency Department

    Grenoble, France · Recruiting

  • La Roche sur Yon Hospital

    La Roche-sur-Yon, France · Not yet recruiting

  • La Rochelle Hospital, Adult emergency departement

    La Rochelle, France · Recruiting

  • Le Mans Hospital, Emergency department

    Le Mans, France · Recruiting

  • Limoges University hospital, Emergency department

    Limoges, France · Recruiting

  • Edouard Herriot University Hospital, Emergency Department

    Lyon, France · Recruiting

  • Marseille University Hospital, Emergency department

    Marseille, France · Recruiting

  • Melun Hospital, Emergency Department

    Melun, France · Recruiting

  • Montpellier University Hospital, emergency department

    Montpellier, France · Recruiting

  • Nancy University Hospital, Emergency department

    Nancy, France · Not yet recruiting

  • Nantes University Hospital, Emergency department

    Nantes, France · Recruiting

  • Nice University Hospital, Emergency department

    Nice, France · Withdrawn

  • Niort Hospital, Emergency Department

    Niort, France · Recruiting

  • Lariboisière hospital, emergency department

    Paris, France · Not yet recruiting

  • Saint-Antoine Hospital, Emergency department

    Paris, France · Recruiting

  • La Pitié-Salpétrière Hospital, Emergency Department

    Paris, France · Not yet recruiting

  • Cochin Hospital, Emergency department

    Paris, France · Recruiting

  • St-Joseph Hospital, Emergency Department

    Paris, France · Recruiting

  • HEGP, Emergency Department

    Paris, France · Recruiting

  • Bichat Hospital, Adult Emergency department

    Paris, France · Recruiting

  • South Lyon University Hospital, Emergency department

    Pierre-Bénite, France · Recruiting

  • Poitiers University Hospital, Emergency department

    Poitiers, France · Recruiting

  • Rennes University Hospital, Emergency department

    Rennes, France · Recruiting

  • Rouen University Hospital, Emergency Department

    Rouen, France · Not yet recruiting

  • Strasbourg University Hospital, Emergency Department

    Strasbourg, France · Recruiting

  • Toulouse University Hospital, Emergency Department

    Toulouse, France · Recruiting

  • Vannes Hospital, Emergency Department

    Vannes, France · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.